Advancements in Automation, Reproducibility and Robustness Enables Research to Scale like Never Before. SCIEX, a global leader in life science analytical technologies, today announced their latest proteomics solution advancements, which address the challenges of throughput, reproducibility and robustness faced by Academic Labs working to advance precision medicine.
Here is the past week’s career-related news from across the Science family of publications.
Two new research papers on scabies and tapeworms published today showcase a new collaboration with protocols.io. This demonstrates a new way to share scientific methods that allows scientists to better repeat and build upon these complicated studies on difficult-to-study parasites. It also highlights a new means of writing all research papers with citable methods that can be updated over time.
Researchers write that "reproducibility,"replicability" and several other terms are not used consistently in scientific communication.
Inspired by a new movement to improve the transparency and reproducibility of research, graduate student John Lurquin wants the University of Colorado to adopt a campus-wide transparent research policy requiring academics to publish data and information about their experiments. Though reproducibility, or the ability to reproduce the results of an experiment, has always been on the minds of researchers, it's been getting more attention recently, thanks to several studies measuring the reliability of published research, said Lurquin, a doctoral student in the department of psychology and neuroscience and an outgoing student body president.
A few years ago, the topic of whether scientific papers are reproducible or not would have been an odd thing to see in a newspaper. But not any more: both the popular media and the journals themselves have been trying to deal with the topic, amid reports that far too many results can’t be replicated. Large scale efforts have begun to examine key papers in experimental psychology, among other areas. Reports from the biopharma industry about the numbers of interesting biology papers that don’t hold up have stirred alarm as well. But as far as I can tell, chemistry has largely escaped the current rounds of criticism.